Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.59−0.13 (-7.56%)
Close on Nov 19, 2026Market cap $4.04MP/E –Yield –
Alaunos Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Alaunos Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $3.00K, down 50.0% year over year. For fiscal 2025 it was $5.00K, down 50.0% from the year before. Over ten years it grew -38.7% a year on average. The highest annual figure on record is $15.90M in fiscal 2017.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.00K | -50.0% |
| FY2024 | Dec 31, 2024 | $10.00K | +100.0% |
| FY2023 | Dec 31, 2023 | $5.00K | -99.8% |
| FY2022 | Dec 31, 2022 | $2.92M | +634.2% |
| FY2021 | Dec 31, 2021 | $398.00K | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $146.00K | -99.1% |
| FY2017 | Dec 31, 2017 | $15.90M | +131.7% |
| FY2016 | Dec 31, 2016 | $6.86M | +757.6% |
| FY2012 | Dec 31, 2012 | $800.00K | +19.9% |
| FY2011 | Dec 31, 2011 | $667.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $3.00K | -25.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.00K | +100.0% |
| Q4 FY2024 | Dec 31, 2024 | $4.00K | +300.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $4.00K | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $1.00K | -90.9% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $4.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2022 | Dec 31, 2022 | $11.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $2.91M | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $0 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $0 | -100.0% |
| Q1 FY2018 | Mar 31, 2018 | $146.00K | -90.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.60M | – |
| Q3 FY2017 | Sep 30, 2017 | $1.60M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.60M | – |
See a number that looks wrong?